GREG ZANTE
CIK 1264949 · Chief Financial Officer · last filed 2026-07-29
GREG ZANTE is a Chief Financial Officer who has filed 35 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for VKTX, was dated Jul 29, 2026. Across all open-market trades the lifetime net is −$26.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.41M
3
35
-$26.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Chief Financial Officer | 233,421 | $31.74 | $7.41M | -$26.05M | 17 | 2026-07-29 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | Chief Financial Officer | 89,751 | $4.60 | $412.9K | $0 | 2 | 2021-01-19 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | VP, Finance & Administration | 0 | $0.18 | $0 | -$430.0K | 6 | 2008-03-12 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-29 | VKTX | Notice (144) | −21,217 | -$710.1K | EDGAR |
| 2026-07-29 | VKTX | Mixed | +10,450 | -$710.1K | EDGAR |
| 2026-01-05 | VKTX | Notice (144) | −57,661 | -$1.90M | EDGAR |
| 2026-01-05 | VKTX | Mixed | +15,388 | -$1.90M | EDGAR |
| 2025-10-28 | VKTX | Notice (144) | −6,185 | -$216.5K | EDGAR |
| 2025-10-28 | VKTX | Mixed | +4,932 | -$216.5K | EDGAR |
| 2025-07-03 | VKTX | Notice (144) | −4,266 | -$118.4K | EDGAR |
| 2025-07-03 | VKTX | Mixed | +3,401 | -$118.4K | EDGAR |
| 2025-01-06 | VKTX | Notice (144) | −50,309 | -$2.15M | EDGAR |
| 2025-01-06 | VKTX | Mixed | +15,891 | -$2.15M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.